May 18, 2023
Voyager Therapeutics
Voyager Therapeutics Presents Robust, Multi-Species Results from Preclinical Studies of IV-Delivered, TRACERâ„¢-Generated Novel Capsids at the ASGCT 26th Annual Meeting
May 15, 2023
Fulcrum Therapeutics
Fulcrum Therapeutics Appoints Alex C. Sapir Chief Executive Officer
May 15, 2023
Fulcrum Therapeutics
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for the First Quarter 2023
May 15, 2023
Decibel Therapeutics
Decibel Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update
May 12, 2023
Decibel Therapeutics
Decibel Therapeutics Announces Approval of Clinical Trial Application by the Spanish Agency of Medicines and Medical Devices (AEMPS) to Initiate Clinical Development of Lead Gene Therapy Candidate DB-OTO